IL33 and lung carcinoma: It has also been reported that in melanoma and colon cancer models IL-33 can effectively promote the function of immune cells to inhibit cancer cells from metastasizing (109, 110), which suggests that the antitumor effect of IL-33 may also be predominant in lung cancer.